यूनाइटेड केयर हॉस्पिटल, एन-3 सिडको · +91 76889 29292 Englishमराठीहिंदी
श्री वी केयर क्लिनिकरक्त रोग एवं कैंसर उपचार केंद्र अपॉइंटमेंट लें
होम › डॉक्टर › डॉ. अनुप तोषणीवाल
Dr. Anup Toshniwal
कैंसर विशेषज्ञ (मेडिकल ऑन्कोलॉजिस्ट)

डॉ. अनुप तोषणीवाल

MBBS, MD (Medicine), DM (Medical Oncology – Tata Memorial Hospital, Mumbai)

डॉ. अनुप तोषणीवाल टाटा मेमोरियल हॉस्पिटल, मुंबई से प्रशिक्षित कैंसर विशेषज्ञ हैं। वे सभी प्रकार के कैंसर और ब्लड कैंसर का कीमोथेरेपी, टार्गेटेड थेरेपी और इम्यूनोथेरेपी से इलाज करते हैं।

विशेषज्ञता

  • Chemotherapy, targeted therapy and immunotherapy for all solid cancers
  • Breast, lung, gastrointestinal, gall bladder, head & neck, gynaecological and urological cancers
  • Lymphoma, leukaemia and myeloma (hemato-oncology)
  • Bone marrow aspiration & biopsy, lumbar puncture, intrathecal chemotherapy
  • Second opinions and tumour board review

शिक्षा

  • MBBS – Government Medical College, Chhatrapati Sambhajinagar
  • MD (General Medicine) – Kasturba Medical College, Mangalore
  • DM (Medical Oncology) – Tata Memorial Hospital, Mumbai
  • ESMO certification – European Society for Medical Oncology
  • ACORD Fellow – Clinical Oncology Research Development workshop, Australia

पद व अनुभव

  • Senior Consultant Medical Oncologist – Medicover Hospital, Chhatrapati Sambhajinagar
  • Associate Professor – Government Cancer Hospital, Chhatrapati Sambhajinagar
  • Former Assistant Professor – Tata Memorial Hospital, Mumbai
  • Teaching faculty for DM (Medical Oncology) and MD (Medicine) courses
  • Director – Shree We Care Clinic

प्रकाशन

  • Downstaging with neoadjuvant chemotherapy in locally advanced gall bladder cancer improves outcomes – Annals of Oncology
  • Toxicity and early outcomes of regorafenib in multiply pre-treated metastatic colorectal adenocarcinoma – experience from a tertiary cancer centre in India
  • Modified 5-FU / leucovorin / irinotecan as a feasible and efficacious second-line regimen in advanced gastric cancer
  • Quality-of-life (Q-TWiST) analysis of a randomised trial comparing cabazitaxel versus docetaxel in recurrent head and neck cancer
  • Efficacy of artesunate for cytomegalovirus reactivation in allogeneic stem cell transplant recipients
  • Use of leflunomide for cytomegalovirus infection in allogeneic stem cell transplant recipients
  • NUT midline carcinoma (case report)
  • Bleomycin-induced skin rash (case report)